Cytori Therapeutics reported $21.24M in Cash and Equivalent for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Baxter International BAX:US $ 2294M 657M
Cerus CERS:US $ 38.37M 10.39M
Cytori Therapeutics CYTX:US $ 21.24M 2.84M
Genocea Biosciences GNCA:US $ 20.14M 17.01M
Haemonetics HAE:US $ 259.5M 22.62M
Infinity Pharmaceuticals INFI:US $ 53.12M 27.6M
Merrimack Pharmaceuticals MACK:US $ 14.29M 91K
Mirati Therapeutics MRTX:US $ 293.42M 100.32M
Northwest Biotherapeutics NWBO:US 6.96M 8.21M
Starpharma Holdings Ltd SPL:AU 51.25M 9.25M
Teva Pharmaceutical TEVA:IT 2.18B 10M